Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in March. Here is a list of some of the biggest funding rounds.
eMed secures $200 million in Series A funding
Miami-based eMed offers GLP-1 programs for employers. In addition to GLP-1 prescriptions, patients gain access to at-home lab testing and health assessments, clinical review and medication management, and ongoing weight and biomarker tracking. They also receive weekly check-ins and 24/7 support.
The $200 million round was led by AON Consulting, with participation from former professional football player Tom Brady; Jeff Aronin, founder, chairman and CEO of Paragon Biosciences; Ara Cohen, co-founder and co-managing member of Knighthead Capital Management; Antonio Gracias, founder and CEO of Valor Equity Partners; and more. The financing will be used to advance eMed’s agentic AI platform and support its balance sheet, according to the announcement.
Nitra snags $187 million in funding
New York-based Nitra aims to make administrative work easier for healthcare practices. Its services include financial automation and providing access to pharmaceuticals and medical equipment products. It also offers AI agents for patient scheduling and insurance eligibility checks.
Nitra’s investors include Actions Capital, Comma Capital, Hyphen Capital, Mana Ventures, Necessary Ventures, New Enterprise Associates, Pantera Capital, Sazze Partners and Soma Capital. It has now raised $205 million in capital and $90 million in equity. The raise will help accelerate AI development, grow its engineering team and scale its operating system.
Grow Therapy raises $150 million in Series D funding
New York City-based Grow Therapy helps independent therapists set up their own in-person and virtual private practices and supports them with administrative tasks like billing and insurance claims. It then helps patients book appointments with therapists who specialize in their needs and are in their network. The company is paid by insurance companies when a Grow Therapy provider visits with an in-network patient.
The company’s Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital. This brings Grow Therapy’s total funding to $328 million. The funding will help expand into employer-sponsored mental health benefits, integrate with primary care and build AI tools.
Qualified Health raises $125 million in Series B funding
Qualified Health helps health systems safely deploy and scale AI. The platform brings together workflow automation, agent development, clinical safeguards, real-time monitoring and governance.
The Series B round was led by New Enterprise Associates (NEA), with participation from Transformation Capital, GreatPoint Ventures, Cathay Innovation, Menlo Ventures’ Anthology Fund, SignalFire, Frist Cressey Ventures, Flare Capital Partners, Healthier Capital, Town Hall Ventures and Intermountain Ventures. The funding will help deepen “existing partnerships, accelerate deployments, and expand the infrastructure required to support health systems as they move from early enterprise AI deployments to broader, system-wide transformation,” according to the announcement.
Picture: Feodora Chiosea, Getty Images